Treatment of Pseudomonas aeruginosa-infected orthopedic prostheses with ceftazidime-ciprofloxacin antibiotic combination.

Antimicrobial Agents and Chemotherapy
P BrouquiD Raoult

Abstract

Indwelling device infections are associated with considerable morbidity and extremely high cost. Pseudomonas aeruginosa is the most frequent gram-negative etiologic agent associated with infections of indwelling catheters and foreign body implants. It is generally agreed that eradication of infection in the presence of a foreign body requires removal of the foreign body. Using a combination of ceftazidime and ciprofloxacin, we cured nine of nine patients with P. aeruginosa-infected osteosynthetic material and four of five patients with hip and knee prostheses without removing the foreign material. Follow-up was for a mean of 21 months (range, 6 to 60 months). Some patients experienced minor side effects (arthralgia in one patient and rash in another patient). We conclude that this combination is effective and safe and should be useful in the treatment of P. aeruginosa-infected orthopedic implants.

References

Jan 1, 1988·Reviews of Infectious Diseases·N Desplaces, J F Acar
Aug 9, 1985·The American Journal of Medicine·L O Gentry
Jul 1, 1984·The American Journal of Medicine·R D InmanC L Christian
Jun 1, 1993·Antimicrobial Agents and Chemotherapy·M DrancourtD Raoult

❮ Previous
Next ❯

Citations

May 18, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J C Martínez-PastorA Soriano
Sep 28, 1998·Biochimica Et Biophysica Acta·D C Hooper
Aug 7, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A F Widmer
Nov 17, 2009·The Journal of Antimicrobial Chemotherapy·J R Samuel, F K Gould
Oct 12, 2010·The Journal of Antimicrobial Chemotherapy·E MoranB L Atkins
May 8, 2004·Journal of Clinical Microbiology·Véronique RouxBernard La Scola
Oct 7, 2005·Journal of Clinical Microbiology·E Botelho-NeversP Brouqui
Feb 6, 2010·Annals of Clinical Microbiology and Antimicrobials·Xavier LemaireEric Senneville
May 27, 2014·Materials Science & Engineering. C, Materials for Biological Applications·Veluchamy PrabhawathiMukesh Doble
Jan 13, 2015·Expert Review of Anti-infective Therapy·Dolors Rodríguez-PardoBenito Almirante
Mar 25, 2009·Journal of Children's Orthopaedics·Antoine HamelGilles Potel
May 4, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J Barberán
Sep 10, 2010·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·C A AboltinsP A Stanley
Apr 29, 2014·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·D Rodríguez-PardoUNKNOWN REIPI Group for the Study of Prosthetic Infection
Jul 15, 2009·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Maria Van GennipThomas Bjarnsholt
Sep 11, 2014·Journal of Biomedical Materials Research. Part a·Wesley L StormMark H Schoenfisch
Jul 4, 2015·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Qi WangThomas J Webster
May 7, 2014·Acta Biomaterialia·Wesley L StormMark H Schoenfisch
Sep 10, 2004·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·G L PavoniM Venditti
Sep 12, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·L LegoutY Mouton
Apr 8, 2016·Expert Opinion on Pharmacotherapy·Concepcion Perez-JorgeJaime Esteban
Oct 6, 2016·Journal of Materials Science. Materials in Medicine·Mario KurtjakDanilo Suvorov
Aug 24, 2019·Journal of Biomedical Materials Research. Part a·James A WroeAndrés J García
Aug 22, 2020·Biomaterials Science·Thomas J HallSophie C Cox
Feb 11, 2020·Frontiers in Microbiology·Muhammad YasirMark D P Willcox
Jan 11, 2020·Frontiers in Cellular and Infection Microbiology·Agata LosPaula Bourke
Feb 27, 2021·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Augustina JeyanathanMelanie J Coathup
Jan 20, 2021·ACS Biomaterials Science & Engineering·Hao WangDacheng Ren

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.